R. Michael Gendreau, Chief Medical Officer at CYPRESS BIOSCIENCE INC (CYPB), bought 5,000 shares at $2.21 ($11K) on 2010-07-08, disclosed to the SEC on 2010-07-09.
Open-market purchase of $11k CYPB by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |